NCT06182280

Brief Summary

Transgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of HIV and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers delivered by peers in one-on-one or small-group settings may be effective at increasing PrEP engagement. This study examines the independent and combined effects of individual and group-based peer-support interventions on PrEP outcomes. Participants will be randomly assigned to receive: (i) standard-of-care HIV prevention information, (ii) a one-on-one healthy lifestyle intervention tailored for transgender masculine people, (iii) a peer-group based healthy lifestyle intervention for transgender masculine people, or (iv) both the one-on-one and group-based interventions delivered together. The hypotheses are that the individual group-based interventions will result in higher PrEP uptake and persistence than the standard of care and that the combined interventions will be more effective than receiving one individual intervention.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
375

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Timeline
13mo left

Started Jan 2024

Typical duration for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jan 2024Jun 2027

First Submitted

Initial submission to the registry

December 13, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 26, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

2.5 years

First QC Date

December 13, 2023

Last Update Submit

December 13, 2023

Conditions

Keywords

TransgenderMen who have sex with menpre-exposure prophylaxisbehavioral interventionHIV prevention

Outcome Measures

Primary Outcomes (1)

  • PrEP uptake

    Uptake of new PrEP prescriptions during the study intervention and follow-up period as measured by biomarker sampling collected by dried blood spots.

    18 months

Secondary Outcomes (1)

  • PrEP adherence and persistence

    18 months

Study Arms (4)

Condition A: Standard of Care (SOC)

NO INTERVENTION

SOC will include linkage to the CDC's HIV Prevention Services Locator, a US directory of HIV testing and PrEP services. A Digital Library of HIV prevention, sexual health, and anti-stigma materials (written and video media) will be provided. This content is curated from CDC, Gate Trans Men \& HIV Project, UCSF Center for Excellence in Trans Health, and National LGBTQIA+ Health Education Center, among other sources.

Condition B: Online one-on-one peer navigation (SOC + PrEP4T)

EXPERIMENTAL

PrEP4T is an individualized TMSM-specific intervention consisting of online one-on-one sessions between a peer and a participant. PrEP4T has 9 hours of content: 6 1.5-hour sessions conducted weekly for 6 weeks. Participants will also receive access to the SOC materials.

Behavioral: PrEP4T

Condition C: Online peer-delivered small group-based behavioral intervention (SOC + LS4TM)

EXPERIMENTAL

LS4TM is a theory-based peer-delivered small group-based behavioral intervention. The LS4TM manualized intervention is comprised of 9 hours of content: 6 2-hour small-group sessions with up to 12 participants per group delivered weekly for 6 weeks. Participants will also receive access to the SOC materials.

Behavioral: LS4TM

Condition D: Peer-delivered and group-based intervention (SOC + PrEP4T + LS4TM)

EXPERIMENTAL

Both PrEP4T and LS4TM will be delivered to participants. Group D will receive 21 hours of content: 6 2-hour LS4TM sessions and 6 1.5-hour PrEP4T sessions. Group D participants may not receive both interventions simultaneously within 6 weeks.

Behavioral: PrEP4TBehavioral: LS4TM

Interventions

PrEP4TBEHAVIORAL

PrEP4T is an individualized TMSM-specific intervention adapted from The Fenway Model. PrEP4T consists of online one-on-one sessions between a peer and a participant using a strengths-based case management manualized curriculum. Peer navigators (PNs) share transmasculine community membership with participants and are trained to provide linkages. They use an individualized approach to navigate barriers, apply an assets-based frame to promote resiliencies, and pragmatically leverage these to improve biomedical HIV prevention outcomes. PNs utilize techniques from established behavior change models (e.g., Motivational Interviewing; Transtheoretical Model) in PrEP decision-making.

Condition B: Online one-on-one peer navigation (SOC + PrEP4T)Condition D: Peer-delivered and group-based intervention (SOC + PrEP4T + LS4TM)
LS4TMBEHAVIORAL

LS4TM is a theory-based peer-delivered small group-based behavioral intervention to reduce HIV risk and address mental health-related effects of stigma for TMSM. Groups will be led by trained peer navigator staff and comprise no more than 10 participants per cohort.

Condition C: Online peer-delivered small group-based behavioral intervention (SOC + LS4TM)Condition D: Peer-delivered and group-based intervention (SOC + PrEP4T + LS4TM)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIdentify as a man, trans man, or another transmasculine identity
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or over
  • Assigned female sex at birth
  • Identifies as a man, trans man, or another transmasculine identity
  • Has had sex with a partner assigned male sex at birth with a flesh penis in the last 3 months
  • Has access to a smartphone or computer with internet access
  • Is HIV-uninfected
  • Resides in one of the Ending the Epidemic targeted geographic hotspots in the United States
  • Willing and able to provide informed consent in English
  • Meets CDC guidelines for PrEP indications in the last 3 months (adapted for TMSM) including:
  • Condomless receptive vaginal/frontal or anal sex with a partner assigned male at birth with a flesh penis
  • Sharing needles or syringes for illicit drug use and/or hormones
  • Self-reported anogenital sexually transmitted infection diagnosis

You may not qualify if:

  • Less than age 18
  • Not assigned female sex at birth
  • Does not identify as a man, trans man, or another transmasculine identity
  • Does not have access to a smartphone or computer
  • Is living with HIV (HIV positive)
  • Does not reside in one of the Ending the Epidemic geographic hotspots in the United States
  • Will not or cannot provide written informed consent in English
  • Does not meet the trans-adapted CDC guidelines for PrEP indications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fenway Community Health

Boston, Massachusetts, 02215, United States

Location

Related Publications (1)

  • Reisner SL, Scheim AI, Cole SW, Wirtz AL, Poteat T, Mimiaga MJ, Marzinke MA, Meyer AI, Smith K, Pletta DR, Mayer KH. Transgender Men and Transmasculine One-on-One and Group-Delivered Empowerment for Targeted HIV Reduction (TOGETHR) Study: Protocol for a Digital Factorial Randomized Controlled Trial. JMIR Res Protoc. 2025 Oct 20;14:e76831. doi: 10.2196/76831.

MeSH Terms

Conditions

HIV InfectionsMedication AdherenceHomosexuality

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehaviorSexualitySexual Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blinding will occur at the statistician and investigator levels, but is not possible for participants or staff in the intervention. Participants will be followed for 18 months.
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: The 2x2 factorial design has two actors: individualized, one-on-one peer navigation (PrEP4T vs none) and group-based behavioral intervention (LS4TM vs none). The comparator is standard-of-care information and resources on HIV prevention and linkage to care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 13, 2023

First Posted

December 26, 2023

Study Start

January 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

December 26, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations